NEUBERGER BERMAN HGH YLD FD's ticker is NHS and the CUSIP is 64128C106. A total of 41 filers reported holding NEUBERGER BERMAN HGH YLD FD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $542,130 | +7.4% | 71,996 | +6.8% | 0.00% | 0.0% |
| Q2 2023 | $504,916 | -20.7% | 67,412 | -9.8% | 0.00% | 0.0% |
| Q1 2023 | $636,853 | -2.5% | 74,748 | -2.4% | 0.00% | 0.0% |
| Q4 2022 | $653,000 | +16.2% | 76,618 | +7.6% | 0.00% | 0.0% |
| Q3 2022 | $562,000 | +0.5% | 71,223 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $559,000 | +1.1% | 67,358 | +39.1% | 0.00% | 0.0% |
| Q1 2022 | $553,000 | -13.7% | 48,428 | -6.2% | 0.00% | 0.0% |
| Q4 2021 | $641,000 | -9.6% | 51,628 | -7.7% | 0.00% | 0.0% |
| Q3 2021 | $709,000 | -9.7% | 55,948 | -5.4% | 0.00% | -50.0% |
| Q2 2021 | $785,000 | -1.4% | 59,148 | -4.2% | 0.00% | 0.0% |
| Q1 2021 | $796,000 | +10.2% | 61,773 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $722,000 | -0.8% | 61,773 | -5.8% | 0.00% | 0.0% |
| Q3 2020 | $728,000 | +7.7% | 65,573 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $676,000 | +27.8% | 65,373 | +7.2% | 0.00% | 0.0% |
| Q1 2020 | $529,000 | – | 60,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shaker Financial Services, LLC | 264,998 | $2,867,000 | 1.41% |
| Vivaldi Capital Management LP | 102,582 | $1,110,000 | 0.91% |
| ROBINSON CAPITAL MANAGEMENT, LLC | 289,112 | $3,128,000 | 0.91% |
| Uncommon Cents Investing LLC | 76,965 | $833,000 | 0.54% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 559,900 | $6,058,000 | 0.48% |
| Saba Capital Management, L.P. | 571,468 | $6,183,000 | 0.38% |
| DOLIVER ADVISORS, LP | 59,204 | $641,000 | 0.27% |
| SHEPHERD KAPLAN KROCHUK, LLC | 33,180 | $359,000 | 0.22% |
| Wunderlich Capital Managemnt | 24,993 | $270,000 | 0.19% |
| AEGON USA Investment Management, LLC | 53,450 | $595,000 | 0.17% |